Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Guided by Chief Experts, Secure Environment Consultants Eliminate Gaps in School Safety Measures
-
ExCellThera Announces Positive Phase 2 Study Results from UM171 Cell Therapy in Patients with High-risk Leukemias and Myelodysplasias at American Society of Hematology (ASH) 2023 Annual Meeting
-
Rogers Accelerates De-Leveraging Plans With Private Sale of Cogeco Shares
-
DAVIDsTEA Reports Financial Results for Third Quarter of Fiscal 2023
-
American Pacific Mining Reports up to 100 g/t Gold and 1,305 g/t Silver from 2023 Rock Chip Sampling at the Recently Expanded Tuscarora Project
-
Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies
-
Lithium Ionic Reports Widest and Highest-Grade Lithium Intercept to Date; Drills 1.72% Li2O Over 53.7m, incl. 1.87% Li2O over 39.5m at Bandeira, Minas Gerais, Brazil
-
Gen II Donates 70 Pieces of Artwork to Local Denver Nonprofits
-
BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day Today
-
ASLAN Pharmaceuticals Provides Year-End Update on Its Eblasakimab and Farudodstat Programs
-
Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer
-
ASLAN Pharmaceuticals Provides Year-End Update on Its Eblasakimab and Farudodstat Programs
-
Mobilicom Chosen by the U.S. Department of Defense for Soldiers’ Next-Generation Wearable Tactical AI-Enhanced Mission Kits
-
Upwork Study Finds 64 Million Americans Freelanced in 2023, Adding $1.27 Trillion to U.S. Economy
-
Growhouse Announces NutraBuddy a Powerful and Scalable AI Platform for E-Commerce Businesses
-
Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies
-
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older
-
C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degrader-Antibody Conjugates (DACs)
-
Enthusiast Gaming Unveils Revamp of Iconic Gaming Portal, Shockwave
-
eQ Plc Managers' Transactions
-
Genmab to Hold 2023 R&D Update and ASH Data Review Meeting
-
EPIC 2024 Announces Agenda with Keynotes to Focus on Culture, Connection, Community, Courage and More
-
Madison Metals Identifies High-Grade Uranium at Khan Project in Namibia
-
Trading in GN Store Nord shares by board members, executives and associated persons
-
BioNTech to Inaugurate First African Site on December 18, 2023
-
Eneti Inc. and Cadeler A/S Share Exhange Offer Expiration Date is December 14, 2023
-
Transocean Ltd. Announces $251 Million Harsh Environment Semisubmersible Contract
-
Alchip Technologies Celebrates 20th Anniversary
-
Glasswing Ventures Unveils Proprietary Framework to Demystify Artificial Intelligence and Empower Business Leaders and Investors Alike
-
Update on Hut 8’s Stalking Horse Bid for four natural gas power plants including the North Bay Bitcoin mine
-
Nxu Announces Expansion of NxuOne™ EV Charging Solutions Network Along NEVI Corridor
-
TENAQUIP Selects eGain for Digital Customer Service
-
Form 8.3 - [Smart Metering Systems plc 11 12 2023] - (CGAML)
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC - 11 12 2023] - (CGWL)
-
NNIT A/S: Change in Board of Directors
-
Form 8.3 - [SMART METERING SYSTEMS PLC - 11 12 2023] - (CGWL)
-
Small Business Loan Approvals Stalled at Big Banks, Rose at Small Banks and Alternative Lenders in November 2023
-
Form 8.3 - [ YOUNG & CO.'S BREWERY PLC 11 12 2023] - (CGWL)
-
Friendlier Secures $5M to Accelerate Nationwide Expansion
-
Canadians Increase E-Commerce Activity During Black Friday Shopping Period Despite 80% Concerned about Falling Victim to Online Fraud Over Holidays – TransUnion study
-
Quest Software Launches Foglight Cloud to Maximize Cloud Infrastructure Performance and Increase Data Accessibility
-
Diffblue Announces Citi as a Strategic Investor
-
Transom Capital Announces Strategic Sale of Mackie to RØDE Microphones
-
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
-
Kelp Is Crafting a Global Currency by Fusing Central Banking Theorem and Blockchain Decentralization
-
Allarity Therapeutics Announces Thomas Jensen as Interim CEO and Appointment of Jeremy R. Graff, PhD as Key Executive Advisor
-
International Travel to Exceed Pre-Pandemic Levels in 2024, Despite slower Chinese Rebound
-
Auriant Mining AB (publ.) announces 2024 production forecast
-
Net Asset Value(s)
-
